162 related articles for article (PubMed ID: 10028050)
1. BCL-2 expression and inhibin-A in adrenal neoplasms: a comparative study.
Fogt F; Zimmerman RL; Mulligan N; Vortmeyer AO; Poremba C; Harris CA; Alsaigh N; Tomaszewski JE; Nikulasson ST
Int J Mol Med; 1999 Mar; 3(3):271-4. PubMed ID: 10028050
[TBL] [Abstract][Full Text] [Related]
2. A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma.
Sangoi AR; McKenney JK
Am J Surg Pathol; 2010 Mar; 34(3):423-32. PubMed ID: 20154585
[TBL] [Abstract][Full Text] [Related]
3. The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study.
Zhang PJ; Genega EM; Tomaszewski JE; Pasha TL; LiVolsi VA
Mod Pathol; 2003 Jun; 16(6):591-7. PubMed ID: 12808065
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic role of inhibin α-subunit and inhibin/activin β-subunit in adrenal cortical and medullary tumors in Egyptian patients.
Elmoneim HM; Samaka RM; Ali H
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):462-9. PubMed ID: 22417854
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical staining of normal, hyperplastic, and neoplastic adrenal cortex with a monoclonal antibody against alpha inhibin.
McCluggage WG; Burton J; Maxwell P; Sloan JM
J Clin Pathol; 1998 Feb; 51(2):114-6. PubMed ID: 9602683
[TBL] [Abstract][Full Text] [Related]
6. Inhibin/activin betaB-subunit expression in pheochromocytomas favors benign diagnosis.
Salmenkivi K; Arola J; Voutilainen R; Ilvesmäki V; Haglund C; Kahri AI; Heikkilä P; Liu J
J Clin Endocrinol Metab; 2001 May; 86(5):2231-5. PubMed ID: 11344232
[TBL] [Abstract][Full Text] [Related]
7. Immunoexpression of inhibin alpha-subunit in adrenal neoplasms.
Cho EY; Ahn GH
Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):222-8. PubMed ID: 11556749
[TBL] [Abstract][Full Text] [Related]
8. Expression of activin and inhibin subunits, receptors and binding proteins in human pheochromocytomas: a study based on mRNA analysis and immunohistochemistry.
Hofland J; van Nederveen FH; Timmerman MA; Korpershoek E; de Herder WW; Lenders JW; Verhofstad AA; de Krijger RR; de Jong FH
Clin Endocrinol (Oxf); 2007 Mar; 66(3):335-40. PubMed ID: 17302865
[TBL] [Abstract][Full Text] [Related]
9. Histopathology and immunohistochemistry of adrenal medullary tumors and paragangliomas.
McNicol AM
Endocr Pathol; 2006; 17(4):329-36. PubMed ID: 17525481
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic value of A103 and inhibin-alpha in adrenocortical tumors: an immunohistochemical study using tissue microarray techniques].
Zhang HY; Wang XJ; Liu WP; Jiang LL; Li GD; Guo J; Zhang YH
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):203-7. PubMed ID: 15256108
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2 staining in pheochromocytomas.
Fogt F; Tomaszewski JE; Vortmeyer AO; Poremba C
Hum Pathol; 1999 Apr; 30(4):486-7. PubMed ID: 10208474
[No Abstract] [Full Text] [Related]
12. Ret protein expression in adrenal medullary hyperplasia and pheochromocytoma.
Powers JF; Brachold JM; Tischler AS
Endocr Pathol; 2003; 14(4):351-61. PubMed ID: 14739491
[TBL] [Abstract][Full Text] [Related]
13. The alpha subunit of inhibin in adrenal cortical neoplasia.
Pelkey TJ; Frierson HF; Mills SE; Stoler MH
Mod Pathol; 1998 Jun; 11(6):516-24. PubMed ID: 9647588
[TBL] [Abstract][Full Text] [Related]
14. A comparison of A103 and inhibin reactivity in adrenal cortical tumors: distinction from hepatocellular carcinoma and renal tumors.
Renshaw AA; Granter SR
Mod Pathol; 1998 Dec; 11(12):1160-4. PubMed ID: 9872645
[TBL] [Abstract][Full Text] [Related]
15. Pathology of adrenal neoplasms.
Saeger W
Minerva Endocrinol; 1995 Mar; 20(1):1-8. PubMed ID: 7651277
[TBL] [Abstract][Full Text] [Related]
16. Mixed corticomedullary carcinoma of the adrenal gland: a case report.
Turk AT; Asad H; Trapasso J; Perilli G; LiVolsi VA
Endocr Pract; 2012; 18(3):e37-42. PubMed ID: 22548942
[TBL] [Abstract][Full Text] [Related]
17. Calretinin and inhibin are useful in separating adrenocortical neoplasms from pheochromocytomas.
Jorda M; De MB; Nadji M
Appl Immunohistochem Mol Morphol; 2002 Mar; 10(1):67-70. PubMed ID: 11893039
[TBL] [Abstract][Full Text] [Related]
18. bcl-2 expression in normal adrenal glands and in adrenal neoplasms.
Fogt F; Vortmeyer AO; Poremba C; Minda M; Harris CA; Tomaszewski JE
Mod Pathol; 1998 Aug; 11(8):716-20. PubMed ID: 9720498
[TBL] [Abstract][Full Text] [Related]
19. The role of immunohistochemistry in histopathological diagnostics of clinically "silent" incidentally detected adrenal masses.
Babinska A; Sworczak K; Wisniewski P; Nałecz A; Jaskiewicz K
Exp Clin Endocrinol Diabetes; 2008 Apr; 116(4):246-51. PubMed ID: 18393131
[TBL] [Abstract][Full Text] [Related]
20. Diverse proportion in composite pheochromocytoma-ganglioneuroma may induce varied clinical symptom: comparison of two cases.
Zhang BY; Zhao M; Li B; Zhang JM
Int J Clin Exp Pathol; 2015; 8(11):15369-74. PubMed ID: 26823896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
